Lam PM et al. |
Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. |
2008 |
Anal. Biochem. |
pmid:18555789
|
Horvath G et al. |
The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. |
2008 |
Pain |
pmid:17533116
|
Moloney GP et al. |
Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor. |
2008 |
Eur J Med Chem |
pmid:17582659
|
Zolese G et al. |
Effect of acylethanolamides on lipid peroxidation and paraoxonase activity. |
2008 |
Biofactors |
pmid:19478424
|
Panagis G et al. |
Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. |
2008 |
Curr Drug Abuse Rev |
pmid:19630731
|
Snider NT et al. |
The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18698000
|
Ortar G et al. |
Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. |
2008 |
Eur J Med Chem |
pmid:17452063
|
Malvindi MA et al. |
Rod-shaped nanocrystals elicit neuronal activity in vivo. |
2008 |
Small |
pmid:18844306
|
Liu J et al. |
Multiple pathways involved in the biosynthesis of anandamide. |
2008 |
Neuropharmacology |
pmid:17631919
|
Shaladi AM et al. |
[Cannabinoids in the control of pain]. |
2008 |
Recenti Prog Med |
pmid:19388223
|
Burstein S |
The elmiric acids: biologically active anandamide analogs. |
2008 |
Neuropharmacology |
pmid:18187165
|
Maccarrone M et al. |
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. |
2008 |
Nat. Neurosci. |
pmid:18204441
|
Paradisi A et al. |
Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. |
2008 |
J. Biol. Chem. |
pmid:18165231
|
Jackson SN et al. |
Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. |
2008 |
Eur. J. Pharmacol. |
pmid:18242598
|
Butt C et al. |
Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. |
2008 |
J. Neurochem. |
pmid:18194436
|
Oddi S et al. |
Evidence for the intracellular accumulation of anandamide in adiposomes. |
2008 |
Cell. Mol. Life Sci. |
pmid:18213445
|
Baldassano S et al. |
Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle. |
2008 |
Eur. J. Pharmacol. |
pmid:18234188
|
Starowicz KM et al. |
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. |
2008 |
Obesity (Silver Spring) |
pmid:18239598
|
Moreira FA et al. |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. |
2008 |
Neuropharmacology |
pmid:17709120
|
Gorzalka BB et al. |
Endocannabinoid modulation of male rat sexual behavior. |
2008 |
Psychopharmacology (Berl.) |
pmid:17694389
|
Potvin S et al. |
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. |
2008 |
J. Psychopharmacol. (Oxford) |
pmid:18308802
|
Hill MN et al. |
Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. |
2008 |
Pharmacopsychiatry |
pmid:18311684
|
Migliarini B and Carnevali O |
Anandamide modulates growth and lipid metabolism in the zebrafish Danio rerio. |
2008 |
Mol. Cell. Endocrinol. |
pmid:18342434
|
Wise LE et al. |
Evaluation of fatty acid amides in the carrageenan-induced paw edema model. |
2008 |
Neuropharmacology |
pmid:17675189
|
De Oliveira Alvares L et al. |
Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. |
2008 |
Neurobiol Learn Mem |
pmid:18342551
|
Palkovits M et al. |
Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. |
2008 |
Neuroscience |
pmid:18343585
|
Fezza F et al. |
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation. |
2008 |
J. Lipid Res. |
pmid:18316795
|
Gertsch J |
Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system. |
2008 |
Planta Med. |
pmid:18275004
|
Roberts LA et al. |
Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. |
2008 |
Neuropharmacology |
pmid:17631916
|
Gonçalves P et al. |
Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells. |
2008 |
Pharmacology |
pmid:18431074
|
McFarland MJ et al. |
RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. |
2008 |
Mol. Pharmacol. |
pmid:18436710
|
Nomura DK et al. |
Activation of the endocannabinoid system by organophosphorus nerve agents. |
2008 |
Nat. Chem. Biol. |
pmid:18438404
|
Ortar G et al. |
New tetrazole-based selective anandamide uptake inhibitors. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18424134
|
Bisogno T |
Endogenous cannabinoids: structure and metabolism. |
2008 |
J. Neuroendocrinol. |
pmid:18426492
|
Capasso R and Izzo AA |
Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. |
2008 |
J. Neuroendocrinol. |
pmid:18426498
|
Ahn K et al. |
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. |
2008 |
Chem. Rev. |
pmid:18429637
|
Rubio M et al. |
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. |
2008 |
Neuropharmacology |
pmid:18371990
|
Evans RM et al. |
Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites. |
2008 |
Br. J. Pharmacol. |
pmid:18376419
|
Di Marzo V and Maccarrone M |
FAAH and anandamide: is 2-AG really the odd one out? |
2008 |
Trends Pharmacol. Sci. |
pmid:18394720
|
Kaufmann I et al. |
Anandamide and neutrophil function in patients with fibromyalgia. |
2008 |
Psychoneuroendocrinology |
pmid:18395993
|
Hegde VL et al. |
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. |
2008 |
Mol. Pharmacol. |
pmid:18388242
|
Solinas M et al. |
The endocannabinoid system in brain reward processes. |
2008 |
Br. J. Pharmacol. |
pmid:18414385
|
Richardson D et al. |
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. |
2008 |
Arthritis Res. Ther. |
pmid:18416822
|
Farrell EK and Merkler DJ |
Biosynthesis, degradation and pharmacological importance of the fatty acid amides. |
2008 |
Drug Discov. Today |
pmid:18598910
|
Terry G et al. |
Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. |
2008 |
Neuroimage |
pmid:18456516
|
Engel MA et al. |
Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide. |
2008 |
J. Physiol. Pharmacol. |
pmid:19212003
|
Mallat A and Lotersztajn S |
Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. |
2008 |
Diabetes Metab. |
pmid:19195630
|
Palmer JA et al. |
Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. |
2008 |
Neuroscience |
pmid:18541380
|
Yang Z et al. |
Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. |
2008 |
Biochem. Pharmacol. |
pmid:18755158
|
Yao F et al. |
Development of novel tail-modified anandamide analogs. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18723350
|
Di Marzo V |
Endocannabinoids: synthesis and degradation. |
2008 |
Rev. Physiol. Biochem. Pharmacol. |
pmid:18481028
|
Pertwee RG |
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. |
2008 |
Addict Biol |
pmid:18482430
|
Rueda-Orozco PE et al. |
Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats. |
2008 |
Neuropharmacology |
pmid:18501388
|
Di Filippo M et al. |
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. |
2008 |
J. Neurol. Neurosurg. Psychiatr. |
pmid:18535023
|
Kase Y et al. |
Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. |
2008 |
Ther Apher Dial |
pmid:18937720
|
Ashton JC et al. |
Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. |
2008 |
Curr. Med. Chem. |
pmid:18537620
|
Njie YF et al. |
N-arachidonylethanolamide-induced increase in aqueous humor outflow facility. |
2008 |
Invest. Ophthalmol. Vis. Sci. |
pmid:18539938
|
Wang J et al. |
Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. |
2008 |
J. Biochem. |
pmid:18806270
|
Murillo-RodrÃguez E et al. |
The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. |
2008 |
Neuroscience |
pmid:18822353
|
Feizi A et al. |
The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. |
2008 |
Exp. Toxicol. Pathol. |
pmid:18571910
|
Woo DH et al. |
Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). |
2008 |
Mol Pain |
pmid:18826653
|
Habayeb OM et al. |
Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. |
2008 |
Endocrinology |
pmid:18599552
|
Waldeck-Weiermair M et al. |
Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. |
2008 |
J. Cell. Sci. |
pmid:18445684
|
Resstel LB et al. |
Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats. |
2008 |
Psychopharmacology (Berl.) |
pmid:18446325
|
Cippitelli A et al. |
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. |
2008 |
Psychopharmacology (Berl.) |
pmid:18446329
|
Liu HY et al. |
[Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors]. |
2008 |
Zhonghua Gan Zang Bing Za Zhi |
pmid:18578993
|
Dembiński A et al. |
Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves. |
2008 |
Eur. J. Pharmacol. |
pmid:18593574
|
Stark K et al. |
Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. |
2008 |
FEBS J. |
pmid:18549450
|
Kamei J et al. |
[Sensitization of cough sensitivity through activation of C-and/or Adelta fibers]. |
2008 |
Nippon Yakurigaku Zasshi |
pmid:18552444
|
Thors L et al. |
Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. |
2008 |
Br. J. Pharmacol. |
pmid:18552875
|
Ellgren M et al. |
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. |
2008 |
Eur Neuropsychopharmacol |
pmid:18674887
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
Hashiguchi T et al. |
Systematic evaluation of nitric oxide, tetrahydrobiopterin, and anandamide levels in a porcine model of endotoxemia. |
2008 |
J Anesth |
pmid:18685926
|
Lisboa SF et al. |
Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. |
2008 |
Eur. J. Pharmacol. |
pmid:18691568
|
Currie S et al. |
IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. |
2008 |
J. Mol. Cell. Cardiol. |
pmid:18692061
|
Ferreri C et al. |
Synthesis of all-trans anandamide: a substrate for fatty acid amide hydrolase with dual effects on rabbit platelet activation. |
2008 |
Bioorg. Med. Chem. |
pmid:18782671
|
Rácz I et al. |
Anandamide effects on 5-HT(3) receptors in vivo. |
2008 |
Eur. J. Pharmacol. |
pmid:18775693
|
Neelands TR et al. |
Elevated temperatures alter TRPV1 agonist-evoked excitability of dorsal root ganglion neurons. |
2008 |
Inflamm. Res. |
pmid:18777111
|
Scherma M et al. |
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18725543
|
Ho WS et al. |
'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. |
2008 |
Br. J. Pharmacol. |
pmid:18695637
|
Woodward DF et al. |
The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. |
2008 |
Pharmacol. Ther. |
pmid:18700152
|
Williams JL et al. |
K+ channel inhibition modulates the biochemical and morphological differentiation of human placental cytotrophoblast cells in vitro. |
2008 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:18703414
|
Moezi L et al. |
Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis. |
2008 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:18703639
|
de Oliveira Alvares L et al. |
Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. |
2008 |
Neuroscience |
pmid:18554811
|
Cella M et al. |
Dual effect of anandamide on rat placenta nitric oxide synthesis. |
2008 |
Placenta |
pmid:18561998
|
Placzek EA et al. |
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. |
2008 |
Neuropharmacology |
pmid:18760289
|
Nakata M and Yada T |
Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors. |
2008 |
Regul. Pept. |
pmid:17884194
|
Haller VL et al. |
Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. |
2008 |
Eur. J. Pharmacol. |
pmid:18762181
|
Astarita G et al. |
Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. |
2008 |
J. Lipid Res. |
pmid:17957091
|
da Veiga MA et al. |
Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. |
2008 |
J. Endocrinol. |
pmid:18755884
|
DeMorrow S et al. |
Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. |
2008 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:18096608
|
Scherma M et al. |
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. |
2008 |
Neuropharmacology |
pmid:17904589
|
Bjursell M et al. |
Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. |
2008 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:18029443
|
Butler RK et al. |
Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. |
2008 |
Pain |
pmid:19004548
|
Williams MA et al. |
The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor. |
2008 |
J. Physiol. (Lond.) |
pmid:18063665
|
Rubino T et al. |
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. |
2008 |
Cereb. Cortex |
pmid:17921459
|
Gyires K and Zádori Z |
[Analysis of central mechanisms involved in gastric mucosal integrity]. |
2008 |
Neuropsychopharmacol Hung |
pmid:18956615
|
Muccioli GG and Stella N |
An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. |
2008 |
Anal. Biochem. |
pmid:17981259
|
Thiemann G et al. |
The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. |
2008 |
Behav. Brain Res. |
pmid:17988751
|
Correa F et al. |
Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). |
2008 |
Biochem. J. |
pmid:17961121
|